News – Page 144 – Endpoints News

International society criticizes Utah law for permitting unapproved stem cell therapies

11 months ago

FDA loosens side effect reporting requirements for some CAR-T therapies

11 months ago

FTC backs plan to target more patent settlements it sees as anticompetitive

11 months ago

Teva and US government discuss settling kickback lawsuit over Copaxone

11 months ago

Intra-Cellular reports a depression win, setting up future competition with AbbVie's Vraylar

11 months ago

Updated: Taysha teases early gene therapy data for Rett syndrome

11 months ago

After two patient deaths from presumed sepsis, FDA puts partial hold on Zentalis studies

11 months ago

Day One enters ADC field, going after a target that once attracted AbbVie and now Genmab

11 months ago

A new obesity biotech; UroGen aims to raise $107M

11 months ago

Hikma to take over several assets from Xellia, including a US manufacturing site

11 months ago

Roche strikes neuro-focused partnership with RNA exon editing startup, worth as much as $1.8B

11 months ago

As it deepens immunology bets, Sanofi inks small molecule pact with Belharra

11 months ago

How two academic chemists turned San Diego startup Iambic into an AI force

11 months ago

Marea Therapeutics launches with $190M, seeing a 'fixable problem' in a neglected cardiometabolic target

11 months ago

AstraZeneca’s Truqap combo flops in Phase 3 triple-negative breast cancer trial

11 months ago

Philips works on tech to connect disparate healthcare and bio-tracking devices

11 months ago

Merck's 21-valent pneumococcal vaccine for adults wins FDA approval

11 months ago

GSK readies Blenrep's commercial re-launch in the US, and a push in second line

11 months ago

FDA approves endometrial cancer indications for Keytruda, Imfinzi

11 months ago

Life sciences investor Decheng Capital targets $700M for fifth fund

11 months ago

Janssen ordered to pay $150M over false claims around HIV drugs

11 months ago

Amgen nabs new Blincyto approval for certain type of leukemia

11 months ago

J&J cements footprint in Italy with €580M in investments over the next 5 years

11 months ago

Argenx drops post-Covid syndrome program; Mirum picks a dose for bile duct disease drug

11 months ago

First page Previous page 141 142 143144145 146 147 Next page Last page